Delmosart PR 18 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 18 mg prolonged-release tablets

actavis group ptc ehf - methylphenidate hydrochloride - prolonged-release tablet - 18 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 27 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 27 mg prolonged-release tablets

actavis group ptc ehf - methylphenidate hydrochloride - prolonged-release tablet - 27 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 54 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 54 mg prolonged-release tablets

actavis group ptc ehf - methylphenidate hydrochloride - prolonged-release tablet - 54 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 36 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 36 mg prolonged-release tablets

actavis group ptc ehf - methylphenidate hydrochloride - prolonged-release tablet - 36 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 18 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 18 mg prolonged-release tablets

accord healthcare ireland ltd. - methylphenidate hydrochloride - prolonged-release tablet - 18 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 27 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 27 mg prolonged-release tablets

accord healthcare ireland ltd. - methylphenidate hydrochloride - prolonged-release tablet - 27 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 36 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 36 mg prolonged-release tablets

accord healthcare ireland ltd. - methylphenidate hydrochloride - prolonged-release tablet - 36 milligram(s) - centrally acting sympathomimetics; methylphenidate

Delmosart PR 54 mg prolonged-release tablets Irska - engleski - HPRA (Health Products Regulatory Authority)

delmosart pr 54 mg prolonged-release tablets

accord healthcare ireland ltd. - methylphenidate hydrochloride - prolonged-release tablet - 54 milligram(s) - centrally acting sympathomimetics; methylphenidate

RITALIN 10 MG TABLETS Izrael - engleski - Ministry of Health

ritalin 10 mg tablets

novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 10 mg - methylphenidate - methylphenidate - attention deficit hyperactivity disorder (adhd). narcolepsy.

CONCERTA 18 MG Izrael - engleski - Ministry of Health

concerta 18 mg

j-c health care ltd - methylphenidate hydrochloride - tablets extended release - methylphenidate hydrochloride 18 mg - methylphenidate - methylphenidate - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd).